- Taking a GLP-1 Medication? Here’s Tips to Holiday Eating
- Bird Flu Virus in Canadian Teen Shows Mutations That Could Help It Spread Among Humans
- Flu, COVID Vaccination Rates Remain Low as Winter Nears
- ’10 Americas:’ Health Disparities Mean Life Expectancy Varies Across U.S.
- Short-Term Hormone Therapy for Menopause Won’t Harm Women’s Brains
- Could a Vitamin Be Effective Treatment for COPD?
- Woman Receives World’s First Robotic Double-Lung Transplant
- Flavored Vapes Behind Big Surge in U.S. E-Cigarette Sales
- Reading Beyond Headline Rare For Most on Social Media, Study Finds
- Meds Like Ozempic Are Causing Folks to Waste More Food
Flu Vaccine May Not Protect Against Main Flu Strain: Study
FRIDAY, Dec. 17, 2021This season’s flu vaccine may do little to prevent infection with the main circulating virus strain because the strain has changed since the vaccine was developed, a new study suggests.
However, the vaccine is still likely to protect against severe illness and death, according to the U.S. researchers. They assessed the vaccine’s effectiveness against the H3N2 strain. The vaccine is also meant to protect against H1N1 and two strains of influenza B.
Lab tests suggest a “major mismatch” between the vaccine and the new, mutated version of H3N2, study leader Scott Hensley, a professor of microbiology at the University of Pennsylvania in Philadelphia, told CNN.
That finding may help explain a flu outbreak at the University of Michigan last month that affected more than 700 people. More than 26% of those who tested positive had been vaccinated — the same percentage as those who tested negative. That suggests the vaccine was not effective in preventing infection, CNN reported.
He said flu viruses constantly mutate and different variants can circulate at the same time. Changes in this mutated version of H3N2 help it dodge the antibodies the body makes in response to flu vaccines.
“Population immunity against influenza viruses is likely low since these viruses have not circulated widely during the COVID-19 pandemic,” Hensley’s team wrote. “Social distancing, mask-wearing, and decreases in international travel have likely contributed to reduced global circulation of influenza viruses. Once COVID-19-related restrictions are eased or lifted, it is possible that influenza viruses will circulate widely due to lack of infection-induced population immunity over the past two years.”
However, Hensley said the changes in the virus probably won’t protect it against immune system T-cells, so this season’s flu vaccine is still likely to prevent severe disease and death.
“Studies have clearly shown that seasonal influenza vaccines consistently prevent hospitalizations and deaths, even in years where there are large antigenic mismatches,” Hensley and colleagues wrote in their report.
The study was posted on a preprint server online and has not been published in a peer-reviewed journal.
The flu kills anywhere between 12,000 and 52,000 people a year, depending on the flu season, and puts as many as 700,000 people into the hospital, according to the CDC.
More information
Visit the U.S. Centers for Disease Control and Prevention for more on the flu.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.